Dane Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 3.60 M
as on 17-12-2024
- Paid Up Capital ₹ 3.50 M
as on 17-12-2024
- Company Age 25 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.27 M
as on 17-12-2024
- Satisfied Charges ₹ 1.08 M
as on 17-12-2024
About Dane Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.60 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹8.27 M. The company has closed loans amounting to ₹1.08 M, as per Ministry of Corporate Affairs (MCA) records.
Sushama Madhavan, Achuvath Gowri, Rohit Gowri, and One other member serve as directors at the Company.
- CIN/LLPIN
U85195KL1999PTC013238
- Company No.
013238
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Palakkad, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dane Diagnostics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushama Madhavan  | Managing Director | 18-Aug-1999 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Achuvath Gowri | Director | 18-Aug-1999 | Current |
| Rohit Gowri | Director | 29-Jan-2019 | Current |
| Pradeep Sukumaran | Director | 29-Jan-2019 | Current |
Financial Performance of Dane Diagnostics.
Dane Diagnostics Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dane Diagnostics?
In 2017, Dane Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 29 Aug 2022 | ₹7.50 M | Open |
State Bank Of India Creation Date: 30 Jul 2009 | ₹0.68 M | Open |
Oriental Bank Of Commerce Creation Date: 29 Jan 2003 | ₹0.09 M | Open |
How Many Employees Work at Dane Diagnostics?
Dane Diagnostics has a workforce of 18 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dane Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dane Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
